Benserazide, CAS 322-35-0

Description: Benserazide is an inhibitor of dopa decarboxylase. It is often given with levodopa in the treatment of Parkinson's to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose.

CAS Number: 322-35-0

Formula: C10H15N3O5

Molecular Weight: 257,24

References: Wan Y, Wu N, Song L, Wang X, Liu Z, Yuan W, Gan J. Levodopa/Benserazide Loaded Microspheres Alleviate L-dopa Induced Dyskinesia through Preventing the Over-Expression of D1R/Shp-2/ERK1/2 Signaling Pathway in a Rat Model of Parkinson's Disease. Front Aging Neurosci. 2017 Oct 18;9:331. doi: 10.3389/fnagi.2017.00331. eCollection 2017. PubMed PMID: 29093677; PubMed Central PMCID: PMC5651254.

• SKU: TGMT1517L-25mg
• Manufacturer: TargetMol Chemicals
• Manufacturer SKU: T1517L-25mg
• Package Unit: 25 mg
• Quantity Unit: STK